We highly recommend enabling Javascript while using the BlackBoxRX site.


Hypersensitivity and Anaphylaxis

  • Hypersensitivity reactions, including anaphylaxis, have been reported during or after the administration of raxibacumab by intravenous infusion¬†[see Warnings and Precautions (5.1)].
  • Administer raxibacumab by intravenous infusion in monitored settings where appropriate equipment, medication (including epinephrine) and personnel trained in the management of hypersensitivity, anaphylaxis, and shock are available¬†[see Warnings and Precautions (2.3,¬†5.1)].

Package Inserts


Additional Information

Updated July 2021